HR Execs on the Move

EcoNugenics

www.econugenics.com

 
EcoNugenics® was founded in 1995 by Dr. Isaac Eliaz, M.D., M.S., L.Ac. - a pioneer and expert in the field of integrative medicine, and a highly regarded clinical practitioner, formulator, researcher and author. Dr. Eliaz leads our research activities in natural, integrative approaches to cellular, immune, metabolic, digestive, and cardiovascular health, as well as detoxification.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details
Val Prisecaru
Senior Director Research Development Profile

Similar Companies

DTI Dental Technologies Inc.

DTI Dental Technologies Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Dublin, CA. To find more information about DTI Dental Technologies Inc., please visit www.dtidental.com

Meissner Filtration Products

Meissner Filtration Products is a Camarillo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eversio Wellness

Located on the majestic West Coast of British Columbia, Eversio Wellness is an expanding mushroom wellness company with big plans for the future of fungi across Canada, the US and beyond. We were founded in February 2020, right before COVID-19 became part of our vocabulary in BC – and the timing couldn`t have been more synergistic for us. Our co-founders are a family of friends with a common goal – to shape how fungi will impact the health of us and our planet. We are ordinary souls who are grateful each day for the extraordinary human experiences we`ve had in holistic nutrition, pharmaceutical sciences, mental health, marketing, business and education. We are a company that strives to be HUMANITY PLUS in every decision we make. Our intention is to offer you something you can use to upgrade your present moment and every moment of life after that! And, it all begins with a connection to the land and the mushrooms we love.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.

Lets Talk Spech Language Svcs

Lets Talk Spech Language Svcs is a Raleigh, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.